Ho William Tai-Wei
SEC CIK 1830914 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INAB | IN8BIO, INC. | Pres, CEO, Dir, 10% | 121.2K | $75.0K | — | 6 | 2021-08-03 | 2025-12-22 |
Most active insiders at INAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rochlin Kate | COO | — | — |
| 2 | McCall Patrick | CFO | — | — |
| 3 | Ho William Tai-Wei | Pres AND CEO, Dir, 10% | — | — |
| 4 | FAIRBAIRN EMILY | Dir | — | — |
| 5 | Roemer Alan S. | Dir | — | — |
| 6 | Brandt Peter C. | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2025-12-22 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres AND CEO, Dir, 10% | A - Grant | $1.38 | +36.2K | 121.2K | +43% | +$50.0K | |
| D | 2024-10-08 | 2024-10-04 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres AND CEO, Dir, 10% | A - Grant | — | +126.6K | 2.55M | +5% | — |
| D | 2023-12-15 | 2023-12-13 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres, CEO, Dir, 10% | A - Grant | — | +82.0K | 2.42M | +4% | — |
| 2023-08-28 | 2023-08-24 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres, CEO, Dir, 10% | P - Purchase | $1.05 | +23.8K | 2.34M | +1% | +$25.0K | |
| 2022-08-18 | 2022-08-16 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres, CEO, CFO, Dir | P - Purchase | $1.90 | +26.3K | 2.32M | +1% | +$50.0K | |
| DI | 2021-08-03 | 2021-08-03 | INAB | IN8BIO, INC. | Ho William Tai-Wei | Pres, CEO, CFO, Dir | C - Cnv Deriv | — | +3,070 | 73.0K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations